{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:59:51Z","timestamp":1792807191706,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100010607","name":"Universit\u00e0 degli Studi di Perugia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010607","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s40257-023-00819-y","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:02:37Z","timestamp":1695106957000},"page":"149-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["AtopyReg\u00ae, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-8141","authenticated-orcid":false,"given":"Luca","family":"Stingeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chiricozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiacomo","family":"Calzavara-Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Schena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M.","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo D.","family":"Pigatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Passante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Romita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natale","family":"Schettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo V.","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Tonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Marietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Casciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Argenziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AtopyReg\u00ae study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaminia","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia L.","family":"Artelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Barei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Berardinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Dastoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagina G.","family":"Mennuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Pascucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"819_CR1","unstructured":"Schuler CF 4th, Billi AC, Maverakis E, et al. Novel insights into atopic dermatitis. J Allergy Clin Immunol. 2022;22:S0091-6749(22)01480-4."},{"issue":"4","key":"819_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.anai.2020.12.020","volume":"126","author":"JI Silverberg","year":"2021","unstructured":"Silverberg JI, Barbarot S, Gadkari A, et al. Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study. Ann Allergy Asthma Immunol. 2021;126(4):417\u201328.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"819_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"S Barbarot","year":"2018","unstructured":"Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284\u201393.","journal-title":"Allergy"},{"issue":"4","key":"819_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/jdv.17094","volume":"35","author":"C Patruno","year":"2021","unstructured":"Patruno C, Napolitano M, Argenziano G, et al. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study. J Eur Acad Dermatol Venereol. 2021;35(4):958\u201364.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"819_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/14737167.2019.1549491","volume":"19","author":"M Gutknecht","year":"2018","unstructured":"Gutknecht M, Reinert R, Augustin M. Review of health economic analyses in atopic dermatitis: how diverse is the literature? Expert Rev Pharmacoecon Outcomes Res. 2018;19(2):127\u201345.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"9","key":"819_CR6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/jdv.18345","volume":"36","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema: part I: systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409\u201331.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"819_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/ijms24010781","volume":"24","author":"K Makowska","year":"2023","unstructured":"Makowska K, Nowaczyk J, Blicharz L, et al. Immunopathogenesis of atopic dermatitis: focus on interleukins as disease drivers and therapeutic targets for novel treatments. Int J Mol Sci. 2023;24(1):781.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"819_CR8","first-page":"1","volume":"157","author":"A Costanzo","year":"2022","unstructured":"Costanzo A, Amerio P, Asero R, et al. Long-term management of moderate-to-severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Association of Italian Territorial and Hospital Allergists and Immunologists (AAIITO), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA), and the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC). Ital J Dermatol Venerol. 2022;157(1):1\u201312.","journal-title":"Ital J Dermatol Venerol"},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2340\/00015555924447","volume":"Suppl 92","author":"JM Hanifin","year":"1980","unstructured":"Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;Suppl 92:44\u20137.","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"1","key":"819_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","volume":"10","author":"JM Hanifin","year":"2001","unstructured":"Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11\u20138.","journal-title":"Exp Dermatol"},{"issue":"6","key":"819_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2340\/00015555-2642","volume":"97","author":"A Reich","year":"2017","unstructured":"Reich A, Chatzigeorkidis E, Zeidler C, Osada N, Furue M, Takamori K, et al. Tailoring the cut-off values of the Visual Analogue Scale and Numeric Rating Scale in itch assessment. Acta Derm Venereol. 2017;97(6):759\u201360.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"819_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/bjd.20783","volume":"186","author":"J Puelles","year":"2022","unstructured":"Puelles J, Fofana F, Rodriguez D, Silverberg JI, Wollenberg A, Dias Barbosa C, et al. Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis. Br J Dermatol. 2022;186(2):285\u201394. https:\/\/doi.org\/10.1111\/bjd.20783.","journal-title":"Br J Dermatol"},{"issue":"3","key":"819_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"819_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jaci.2014.07.043","volume":"134","author":"J Schmitt","year":"2014","unstructured":"Schmitt J, Spuls PI, Thomas KS, Simpson E, Furue M, Deckert S, et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134(4):800\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.043.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"819_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jaad.2015.09.062","volume":"74","author":"M Futamura","year":"2016","unstructured":"Futamura M, Leshem YA, Thomas KS, Nankervis H, Williams HC, Simpson EL. A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: many options, no standards. J Am Acad Dermatol. 2016;74(2):288\u201394. https:\/\/doi.org\/10.1016\/j.jaad.2015.09.062.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"819_CR16","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/bjd.12590","volume":"169","author":"C Charman","year":"2013","unstructured":"Charman C, Venn A, Ravenscroft J, Williams H. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol. 2013;169(6):1326\u201332.","journal-title":"Br J Dermatol"},{"key":"819_CR17","doi-asserted-by":"publisher","first-page":"204062232110029","DOI":"10.1177\/20406223211002979","volume":"12","author":"G Girolomoni","year":"2021","unstructured":"Girolomoni G, de Bruin-Weller M, Aoki V, et al. Nomenclature and clinical phenotypes of atopic dermatitis. Ther Adv Chronic Dis. 2021;12:20406223211002980.","journal-title":"Ther Adv Chronic Dis."},{"issue":"2","key":"819_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.18176\/jiaci.0138","volume":"27","author":"JF Silvestre Salvador","year":"2017","unstructured":"Silvestre Salvador JF, Romero-P\u00e9rez D, Encabo-Dur\u00e1n B. Atopic dermatitis in adults: a diagnostic challenge. J Investig Allergol Clin Immunol. 2017;27(2):78\u201388. https:\/\/doi.org\/10.18176\/jiaci.0138.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"10","key":"819_CR19","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.3390\/ijms23105518","volume":"23","author":"YC Tsai","year":"2022","unstructured":"Tsai YC, Tsai TF. Overlapping features of psoriasis and atopic dermatitis: from genetics to immunopathogenesis to phenotypes. Int J Mol Sci. 2022;23(10):5518.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"819_CR20","first-page":"81","volume":"158","author":"G Fabbrocini","year":"2023","unstructured":"Fabbrocini G, Stingeni L, Hansel K, et al. AtopyReg\u00ae: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST. Ital J Dermatol Venerol. 2023;158(2):81\u20133.","journal-title":"Ital J Dermatol Venerol."},{"issue":"1","key":"819_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/jdv.18566","volume":"37","author":"AL Bosma","year":"2023","unstructured":"Bosma AL, Musters AH, Bloem M, et al. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce. J Eur Acad Dermatol Venereol. 2023;37(1):123\u201336.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"819_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/cea.14237","volume":"53","author":"G Birdi","year":"2023","unstructured":"Birdi G, Larkin M, Chua SL, Knibb RC. Quality of life and mental well-being of adults with atopic dermatitis living in the UK. Clin Exp Allergy. 2023;53(1):113\u20137.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"819_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/bjd\/ljac132","volume":"188","author":"EI Adesanya","year":"2023","unstructured":"Adesanya EI, Matthewman J, Schonmann Y, et al. Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2023;188(4):460\u201370.","journal-title":"Br J Dermatol"},{"issue":"1","key":"819_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bjd.18652","volume":"182","author":"S Williamson","year":"2020","unstructured":"Williamson S, Merritt J, De Benedetto A. Atopic dermatitis in the elderly: a review of clinical and pathophysiological hallmarks. Br J Dermatol. 2020;182(1):47\u201354.","journal-title":"Br J Dermatol"},{"key":"819_CR25","volume-title":"Livelli di istruzione e ritorni occupazionali","author":"Istituto Nazionale di Statistica","year":"2022","unstructured":"Istituto Nazionale di Statistica. Livelli di istruzione e ritorni occupazionali. Rome: ISTAT; 2022."},{"issue":"6","key":"819_CR26","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/jdv.16078","volume":"34","author":"A Heratizadeh","year":"2020","unstructured":"Heratizadeh A, Haufe E, St\u00f6lzl D, et al. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany. J Eur Acad Dermatol Venereol. 2020;34(6):1263\u201372.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"819_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2340\/00015555-3082","volume":"99","author":"RF Ofenloch","year":"2019","unstructured":"Ofenloch RF, Schuttelaar ML, Svensson \u00c5, et al. Socioeconomic status and the prevalence of skin and atopic diseases in five European countries. Acta Derm Venereol. 2019;99(3):309\u201314.","journal-title":"Acta Derm Venereol"},{"key":"819_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-3-319-64804-0_8","volume":"1027","author":"AS Adamson","year":"2017","unstructured":"Adamson AS. The economics burden of atopic dermatitis. Adv Exp Med Biol. 2017;1027:79\u201392.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"819_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jaad.2021.09.018","volume":"86","author":"H Bajwa","year":"2022","unstructured":"Bajwa H, Baghchechi M, Mujahid M, Kang Dufour MS, Langan SM, Abuabara K. Mixed evidence on the relationship between socioeconomic position and atopic dermatitis: a systematic review. J Am Acad Dermatol. 2022;86(2):399\u2013405.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"819_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jamadermatol.2021.0008","volume":"157","author":"J Wan","year":"2021","unstructured":"Wan J, Mitra N, Hooper SR, Hoffstad OJ, Margolis DJ. Association of atopic dermatitis severity with learning disability in children. JAMA Dermatol. 2021;157(6):651\u20137.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"819_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamadermatol.2021.0009","volume":"157","author":"SAJ Schmidt","year":"2021","unstructured":"Schmidt SAJ, Mailhac A, Darvalics B, et al. Association between atopic dermatitis and educational attainment in Denmark. JAMA Dermatol. 2021;157(6):1\u20139.","journal-title":"JAMA Dermatol"},{"issue":"9","key":"819_CR32","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/jdv.17346","volume":"35","author":"K P\u00e1lsson","year":"2021","unstructured":"P\u00e1lsson K, Slagor RM, Flachs EM, N\u00f8rreslet LB, Agner T, Ebbeh\u00f8j NE. Childhood atopic dermatitis is associated with a decreased chance of completing education later in life: a register-based cohort study. J Eur Acad Dermatol Venereol. 2021;35(9):1849\u201358.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"819_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/jdv.14523","volume":"32","author":"LB N\u00f8rreslet","year":"2018","unstructured":"N\u00f8rreslet LB, Ebbeh\u00f8j NE, Ellekilde Bonde JP, Thomsen SF, Agner T. The impact of atopic dermatitis on work life: a systematic review. J Eur Acad Dermatol Venereol. 2018;32(1):23\u201338.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"819_CR34","volume-title":"Comunicato stampa n\u00b039\/2022","author":"Istituto Superiore di Sanit\u00e0","year":"2022","unstructured":"Istituto Superiore di Sanit\u00e0. Comunicato stampa n\u00b039\/2022. Rome: ISS; 2022."},{"key":"819_CR35","volume-title":"Il Consumo di Alcol in Italia","author":"Istituto Nazionale di Statistica","year":"2017","unstructured":"Istituto Nazionale di Statistica. Il Consumo di Alcol in Italia. Rome: ISTAT; 2017."},{"issue":"6","key":"819_CR36","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/jdv.12784","volume":"29","author":"G Pesce","year":"2015","unstructured":"Pesce G, Marcon A, Carosso A, et al. Adult eczema in Italy: prevalence and associations with environmental factors. J Eur Acad Dermatol Venereol. 2015;29(6):1180\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"819_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","volume":"123","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(2):144\u201351.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"819_CR38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40257-019-00453-7","volume":"20","author":"PP Vakharia","year":"2019","unstructured":"Vakharia PP, Silverberg JI. Adult-onset atopic dermatitis: characteristics and management. Am J Clin Dermatol. 2019;20(6):771\u20139.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"819_CR39","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jaci.2017.01.008","volume":"139","author":"T Bieber","year":"2017","unstructured":"Bieber T, D\u2019Erme AM, Akdis CA, et al. Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go? J Allergy Clin Immunol. 2017;139(4):S58-64.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"819_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clindermatol.2017.03.007","volume":"35","author":"NB Silverberg","year":"2017","unstructured":"Silverberg NB. Typical and atypical clinical appearance of atopic dermatitis. Clin Dermatol. 2017;35(4):354\u20139.","journal-title":"Clin Dermatol"},{"issue":"4","key":"819_CR41","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/ACI.0000000000000837","volume":"22","author":"C Patruno","year":"2022","unstructured":"Patruno C, Potestio L, Napolitano M. Clinical phenotypes of adult atopic dermatitis and related therapies. Curr Opin Allergy Clin Immunol. 2022;22(4):242\u20139.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7","key":"819_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/jdv.15574","volume":"33","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI, Margolis DJ, Boguniewicz M, et al. Distribution of atopic dermatitis lesions in United States adults. J Eur Acad Dermatol Venereol. 2019;33(7):1341\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"819_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5021\/ad.21.282","volume":"34","author":"J Yoo","year":"2022","unstructured":"Yoo J, Koo HYR, Han K, Lee YB. Impairment of quality of life and mental health status in adult-onset atopic dermatitis. Ann Dermatol. 2022;34(4):278\u201386.","journal-title":"Ann Dermatol"},{"issue":"3","key":"819_CR44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjd.15928","volume":"178","author":"AM Drucker","year":"2018","unstructured":"Drucker AM, Eyerich K, de Bruin-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol. 2018;178(3):768\u201375.","journal-title":"Br J Dermatol"},{"issue":"1","key":"819_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaad.2017.12.077","volume":"79","author":"A He","year":"2018","unstructured":"He A, Feldman SR, Fleischer AB. An assessment of the use of antihistamines in the management of atopic dermatitis. J Am Acad Dermatol. 2018;79(1):92\u20136.","journal-title":"J Am Acad Dermatol"}],"updated-by":[{"DOI":"10.1007\/s40257-023-00822-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000}}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-023-00819-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T19:19:15Z","timestamp":1705605555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-023-00819-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1007\/s40257-023-00819-y","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40257-023-00822-3","asserted-by":"object"}]},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"28 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40257-023-00822-3","URL":"https:\/\/doi.org\/10.1007\/s40257-023-00822-3","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Universit\u00e0 degli Studi di Perugia within the CRUI-CARE Agreement. No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Luca Stingeni has been the principal investigator in clinical trials sponsored by and\/or and has received personal fees for participation in advisory boards from AbbVie, Leo Pharma, Lilly, Novartis, Pfizer, and Sanofi, outside the submitted work. Andrea Chiricozzi received consulting fees from AbbVie, Almirall, Lilly, Leo Pharma, Pfizer, Sanofi, Janssen, Bristol Myers Squibb, and Boehringer Ingelheim, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Lilly, Leo Pharma, Sanofi, and Janssen, outside the submitted work. Piergiacomo Calzavara-Pinton received consulting fee from AbbVie, Sanofi, Janssen, Incyte, Leo, Almirall, Galderma, Cantabria, Boehringer, Novartis, and BMS. Maddalena Napolitano received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Sanofi, AbbVie, Leo Pharma, Lilly, and Amgen, outside the submitted work. Ketty Peris received consulting fees from Sanofi, grants or contracts from Sanofi, Novartis, AbbVie, and Almirall, payment or honoraria for speakers bureaus from Lilly, Sanofi, and Sun Pharma, personal fees for participation in advisory board from AbbVie, Almirall, Leo Pharma, Lilly, Janssen, Sanofi, Pierre Fabre, Sun Pharma, Biogen, Galderma, and Philogen. Cataldo Patruno received consulting fees from AbbVie, Eli Lilly, Leo Pharma, Pfizer, Sanofi, and Pierre Fabre, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Eli Lilly, Leo Pharma, Pfizer, Sanofi, Novartis, and Pierre Fabre. Caterina Foti received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Almirall, Leo Pharma, Lilly, Novartis, and Sanofi. Maria C. Fargnoli received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events and participation on a data safety monitoring board or advisory board from AbbVie, Leo Pharma, Pfizer, Sanofi, and Galderma. Monica Corazza received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Almirall, Lilly, Leo Pharma, Novartis, Sanofi, Janssen, and Pfizer. Silvia M. Ferrucci received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Lilly and Menarini, and participation on a data safety monitoring board or advisory board from AbbVie. Paolo D. Pigatto received consulting fees from AbbVie, Almirall, Leo Pharma, and Sanofi, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Lilly, Leo Pharma, and Sanofi. Gabriella Fabbrocini received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Sanofi, AbbVie, Leo Pharma, Lilly, Amgen, NOVARTIS, Pfizer, UCB, Janssen, and Abiogen. Giampiero Girolomoni received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Abiogen, Almirall, Amgen, Biogen, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli-Lilly, Leo Pharma, Merck Serono, Novartis, Pfizer, Samsung Bioepis, and Sanofi. Paolo Romita received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Novartis, and Sanofi, and for participation of an advisory board from AbbVie. Maria Esposito received consulting fees and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, LEO Pharma, Eli Lilly, and Sanofi. Angelo V. Marzano received consulting fees AbbVie, Boehringer-Ingelheim, Novartis, Pfizer, Sanofi, and UCB. Katharina Hansel received payment or honoraria for lectures, presentations, speakers bureaus, or educational events from AbbVie, Ganassini, Leo Pharma, Lilly, Novartis, and Sanofi, outside the submitted work. Donatella Schena, Mariateresa Rossi, Marco Romanelli, Maria Passante, Natale Schettini, Giulia Tonini, Rossella Marietti, Gabriele Casciola, and Giuseppe Argenziano have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"AtopyReg<sup>\u00ae<\/sup> project was approved by the Ethical Committee of Brescia (Italy), the Study Coordinator Center (approval number: 0013530).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients provided written informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The data that support the findings of this study are available on request from the authors.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization: LS (equal), AC (equal), PC-P (equal); investigation: all authors contributed equally; data curation: LS (equal), GC (equal), KH (equal); formal analysis: LS (equal), AC (equal), KH (equal); methodology: LS (lead); writing: LS (equal), AC (equal), GC (equal), KH (equal); review\/editing: all authors contributed equally. All authors read and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}